Zarrabian Saiid's Form 4 filing
TuHURA Biosciences, Inc. (HURA) · filed Dec 8, 2021
- Accession no.
- 0000899243-21-047320
- Filed
- Dec 8, 2021
- Trade date
- Dec 6-7, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $31.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zarrabian SaiidCIK 0001495521 | Director, Officer (Head of Strategic Partnerships) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | Common Stock | PPurchaseAcquired | +11,891 | $0.59 | +$7,015.69 | 17,391 | Direct | |
| Dec 7, 2021 | Common Stock | PPurchaseAcquired | +38,109 | $0.64 | +$24,389.76 | 55,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.